These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38896263)

  • 21. Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.
    Wozniak JR; Mueller BA; Lim KO; Hemmy LS; Day JW
    J Neurol Sci; 2014 Jun; 341(1-2):73-8. PubMed ID: 24768314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.
    Cabada T; Díaz J; Iridoy M; López P; Jericó I; Lecumberri P; Remirez B; Seijas R; Gomez M
    Neuroradiology; 2021 Jul; 63(7):1019-1029. PubMed ID: 33237431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I.
    Lopez-Titla MM; Chirino A; Cruz Solis SV; Hernandez-Castillo CR; Diaz R; Márquez-Quiroz LDC; Magaña JJ; Beltrán-Parrazal L; Fernandez-Ruiz J
    J Neuroimaging; 2021 Jan; 31(1):192-198. PubMed ID: 32936994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities.
    Giorgio A; Dotti MT; Battaglini M; Marino S; Mortilla M; Stromillo ML; Bramanti P; Orrico A; Federico A; De Stefano N
    J Neurol; 2006 Nov; 253(11):1471-7. PubMed ID: 16786209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.
    Vielhaber S; Jakubiczka S; Gaul C; Schoenfeld MA; Debska-Vielhaber G; Zierz S; Heinze HJ; Niessen HG; Kaufmann J
    Muscle Nerve; 2006 Aug; 34(2):145-52. PubMed ID: 16642499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2.
    Timchenko L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2.
    Mijajlovic M; Bozovic I; Pavlovic A; Rakocevic-Stojanovic V; Gluscevic S; Stojanovic A; Basta I; Meola G; Peric S
    Heliyon; 2024 Mar; 10(5):e26856. PubMed ID: 38434309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Bosè F; Renna LV; Fossati B; Arpa G; Labate V; Milani V; Botta A; Micaglio E; Meola G; Cardani R
    Front Neurol; 2019; 10():992. PubMed ID: 31611837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal Cortical Thickness Is Associated With Deficits in Social Cognition in Patients With Myotonic Dystrophy Type 1.
    Serra L; Bianchi G; Bruschini M; Giulietti G; Domenico CD; Bonarota S; Petrucci A; Silvestri G; Perna A; Meola G; Caltagirone C; Bozzali M
    Front Neurol; 2020; 11():113. PubMed ID: 32180756
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.
    Peric S; Maksimovic R; Banko B; Durdic M; Bjelica B; Bozovic I; Balcik Y; Pesovic J; Savic-Pavicevic D; Rakocevic-Stojanovic V
    J Neurol; 2017 Sep; 264(9):1899-1908. PubMed ID: 28756605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
    Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
    Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
    Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.